HK1165278A1 - Encapsulated liver cell composition - Google Patents
Encapsulated liver cell compositionInfo
- Publication number
- HK1165278A1 HK1165278A1 HK12105890.6A HK12105890A HK1165278A1 HK 1165278 A1 HK1165278 A1 HK 1165278A1 HK 12105890 A HK12105890 A HK 12105890A HK 1165278 A1 HK1165278 A1 HK 1165278A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- liver cell
- cell composition
- encapsulated liver
- encapsulated
- erythropoietin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/430,330 US20100272816A1 (en) | 2009-04-27 | 2009-04-27 | Microcapsules comprising liver cells and erythropoietin, methods for preparing said microcapsules and methods for treating a patient comprising applying said microcapsules to the patient |
PCT/EP2010/002563 WO2010124837A2 (fr) | 2009-04-27 | 2010-04-27 | Composition à base de cellules hépatiques encapsulées |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1165278A1 true HK1165278A1 (en) | 2012-10-05 |
Family
ID=42790675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12105890.6A HK1165278A1 (en) | 2009-04-27 | 2012-06-15 | Encapsulated liver cell composition |
Country Status (26)
Country | Link |
---|---|
US (3) | US20100272816A1 (fr) |
EP (1) | EP2424510B1 (fr) |
JP (1) | JP5702771B2 (fr) |
KR (1) | KR101372384B1 (fr) |
CN (2) | CN102413820B (fr) |
AU (1) | AU2010243888C1 (fr) |
BR (1) | BRPI1014835A8 (fr) |
CL (1) | CL2011002689A1 (fr) |
CY (1) | CY1114464T1 (fr) |
DK (1) | DK2424510T3 (fr) |
ES (1) | ES2431297T3 (fr) |
HK (1) | HK1165278A1 (fr) |
HR (1) | HRP20130963T1 (fr) |
IL (1) | IL215887A (fr) |
MX (1) | MX2011010993A (fr) |
NZ (1) | NZ595511A (fr) |
PL (1) | PL2424510T3 (fr) |
PT (1) | PT2424510E (fr) |
RS (1) | RS52989B (fr) |
RU (2) | RU2564924C2 (fr) |
SG (1) | SG175792A1 (fr) |
SI (1) | SI2424510T1 (fr) |
SM (1) | SMT201300111B (fr) |
UA (1) | UA99686C2 (fr) |
WO (1) | WO2010124837A2 (fr) |
ZA (1) | ZA201106817B (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI669843B (zh) * | 2014-07-25 | 2019-08-21 | 日商積水化學工業股份有限公司 | 具備二次電池之發電裝置 |
WO2016183231A1 (fr) | 2015-05-12 | 2016-11-17 | Baker Group, LLP | Procédé et système pour un organe bioartificiel |
RU2618989C1 (ru) * | 2016-03-09 | 2017-05-11 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Способ лечения печеночной недостаточности |
CN110129253A (zh) * | 2016-09-14 | 2019-08-16 | 四川蓝光英诺生物科技股份有限公司 | 人工组织前体及制备其的方法 |
US11439731B2 (en) | 2016-09-14 | 2022-09-13 | Revotek Co., Ltd. | Artificial tissue progenitor and method for preparing the same |
WO2018093069A1 (fr) * | 2016-11-15 | 2018-05-24 | 광주과학기술원 | Procédé de culture 3d d'une cellule |
EP3943129A4 (fr) * | 2019-03-20 | 2022-12-14 | Public University Corporation Yokohama City University | Agent de revêtement-fixation |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5455790A (en) | 1977-10-05 | 1979-05-04 | Tomoyuki Tajima | Production of erythropoetin |
JPS6045849B2 (ja) | 1980-08-25 | 1985-10-12 | 林原 健 | ヒトエリトロポエチンの製造方法 |
NZ210501A (en) | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
US4956128A (en) * | 1984-05-25 | 1990-09-11 | Connaught Laboratories Limited | Droplet generation |
IL77081A (en) | 1984-12-04 | 1999-10-28 | Genetics Inst | AND sequence encoding human erythropoietin, a process for its preparation and a pharmacological preparation of human erythropoietin |
US5084350A (en) * | 1990-02-16 | 1992-01-28 | The Royal Institution For The Advance Of Learning (Mcgill University) | Method for encapsulating biologically active material including cells |
WO1994025055A1 (fr) | 1993-04-29 | 1994-11-10 | Abbott Laboratories | Procedes et compositions d'analogues d'erythropoïetine |
IL110669A (en) | 1993-08-17 | 2008-11-26 | Kirin Amgen Inc | Erythropoietin analogs |
RU94030310A (ru) * | 1994-08-16 | 1996-08-10 | Молдавский научно-исследовательский институт профилактической и клинической медицины МЗ Республики Молдова (MD) | Способ культивирования клеток человека и животных |
US6281015B1 (en) * | 1994-12-16 | 2001-08-28 | Children's Medical Center Corp. | Localized delivery of factors enhancing survival of transplanted cells |
PL375067A1 (en) | 2002-07-19 | 2005-11-14 | Vesta Therapeutics, Inc. | Method of obtaining viable human liver cells, including hepatic stem/progenitor cells |
CA2550301A1 (fr) * | 2003-12-30 | 2005-07-14 | Bionethos Holding Gmbh | Procede de regeneration de tissus |
CA2561725A1 (fr) * | 2004-03-30 | 2005-10-13 | Fac8Cell Pty Limited | Culture et utilisation de cellules secretant des facteurs de secretion hepatique |
US20090214660A1 (en) * | 2005-10-21 | 2009-08-27 | Living Cell Products Pty Limited | Encapsulation system |
-
2009
- 2009-04-27 US US12/430,330 patent/US20100272816A1/en not_active Abandoned
-
2010
- 2010-04-27 WO PCT/EP2010/002563 patent/WO2010124837A2/fr active Application Filing
- 2010-04-27 JP JP2012506407A patent/JP5702771B2/ja not_active Expired - Fee Related
- 2010-04-27 SI SI201030374T patent/SI2424510T1/sl unknown
- 2010-04-27 PL PL10721304T patent/PL2424510T3/pl unknown
- 2010-04-27 RU RU2013143436/15A patent/RU2564924C2/ru active
- 2010-04-27 EP EP10721304.3A patent/EP2424510B1/fr active Active
- 2010-04-27 KR KR1020117028010A patent/KR101372384B1/ko active IP Right Grant
- 2010-04-27 RU RU2011148106/15A patent/RU2500390C2/ru active
- 2010-04-27 BR BRPI1014835A patent/BRPI1014835A8/pt not_active Application Discontinuation
- 2010-04-27 NZ NZ595511A patent/NZ595511A/xx not_active IP Right Cessation
- 2010-04-27 RS RS20130454A patent/RS52989B/en unknown
- 2010-04-27 UA UAA201112582A patent/UA99686C2/ru unknown
- 2010-04-27 CN CN2010800188449A patent/CN102413820B/zh not_active Expired - Fee Related
- 2010-04-27 US US13/263,352 patent/US8535923B2/en not_active Expired - Fee Related
- 2010-04-27 AU AU2010243888A patent/AU2010243888C1/en not_active Ceased
- 2010-04-27 ES ES10721304T patent/ES2431297T3/es active Active
- 2010-04-27 MX MX2011010993A patent/MX2011010993A/es active IP Right Grant
- 2010-04-27 DK DK10721304.3T patent/DK2424510T3/da active
- 2010-04-27 PT PT107213043T patent/PT2424510E/pt unknown
- 2010-04-27 SG SG2011078375A patent/SG175792A1/en unknown
- 2010-04-27 CN CN201310424282.3A patent/CN103638002B/zh not_active Expired - Fee Related
-
2011
- 2011-09-19 ZA ZA2011/06817A patent/ZA201106817B/en unknown
- 2011-10-24 IL IL215887A patent/IL215887A/en active IP Right Grant
- 2011-10-27 CL CL2011002689A patent/CL2011002689A1/es unknown
-
2012
- 2012-06-15 HK HK12105890.6A patent/HK1165278A1/xx not_active IP Right Cessation
-
2013
- 2013-09-16 US US14/027,932 patent/US9517247B2/en active Active
- 2013-10-04 SM SM201300111T patent/SMT201300111B/xx unknown
- 2013-10-09 CY CY20131100876T patent/CY1114464T1/el unknown
- 2013-10-10 HR HRP20130963AT patent/HRP20130963T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1165278A1 (en) | Encapsulated liver cell composition | |
EP2650342A4 (fr) | Luminophore sphérique, matériau de scellement pour batteries solaires de type à conversion de longueur d'onde, module de batterie solaire, et procédé pour la fabrication de ceux-ci | |
EP2416409A4 (fr) | Matériau actif d'électrode positive pour batterie au lithium | |
EP2416411A4 (fr) | Matériau actif d'électrode positive pour batterie lithium ion | |
EP2215674A4 (fr) | Conception de cellule de batterie avec bornes asymétriques | |
HK1205684A1 (en) | Pellets comprising an active substance matrix resistant to gastric juice | |
EP2506314A4 (fr) | Procédé de fabrication d'électrode avant de cellule solaire | |
HK1201380A1 (en) | Electrochemical cell packaging material | |
EP2752925A4 (fr) | Matériau actif d'électrode positive pour batteries au sodium et son procédé de production | |
SG11201400942YA (en) | Memory cells and memory cell arrays | |
ZA201001436B (en) | Pluripotent stem cell differentiation by using human feeder cells | |
EP2144313A4 (fr) | Procédé de production d'un matériau actif pour électrode positive de batterie | |
EP2220707A4 (fr) | Procédé de production de matériau actif d'électrode pour une pile lithium-ion | |
HK1221333A1 (zh) | 光電極材料及光電池材料 | |
EP2427913A4 (fr) | Techniques d'assemblage pour des réseaux de cellules solaires et cellules solaires formées à partir de celles-ci | |
ZA201202364B (en) | Dye sensitised solar cell | |
SG11201406117PA (en) | Encapsulating material for solar cell and solar cell module | |
EP2244323A4 (fr) | Composition de polyélectrolyte, procédé de production de celle-ci et pile à combustible | |
IL218111A0 (en) | Enhanced efficiency of induced pluripotent stem cell generation from human somatic cells | |
EP2630659A4 (fr) | Ensemble de circuits intégrés comprenant des cellules de mémoire non volatile et procédés permettant de former une cellule de mémoire non volatile | |
MY153067A (en) | Encapsulated liver cell composition | |
EP2635305A4 (fr) | Augmentation des réponses des cellules mémoires th17 spécifiques d'un agent pathogène | |
EP2602857A4 (fr) | Accumulateur alcalin et procédé de fabrication de matière d'électrode positive destinée à un accumulateur alcalin | |
FR2989222B1 (fr) | Materiau d'encapsulation de cellules photovoltaiques | |
HK1169885A1 (en) | Dye sensitised solar cell and method of manufacture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210426 |